125 related articles for article (PubMed ID: 34815249)
1. Continuous subcutaneous infusion: is community anticipatory prescribing and administration safe?
Coyle S; Sinden R; Wignall-Coyle J; Benson S; Powell P; Monnery D
BMJ Support Palliat Care; 2024 Jan; 13(e3):e1373-e1378. PubMed ID: 34815249
[TBL] [Abstract][Full Text] [Related]
2. Unwelcome memento mori or best clinical practice? Community end of life anticipatory medication prescribing practice: A mixed methods observational study.
Bowers B; Pollock K; Barclay S
Palliat Med; 2022 Jan; 36(1):95-104. PubMed ID: 34493122
[TBL] [Abstract][Full Text] [Related]
3. End-of-life care in COVID-19: An audit of pharmacological management in hospital inpatients.
Jackson T; Hobson K; Clare H; Weegmann D; Moloughney C; McManus S
Palliat Med; 2020 Oct; 34(9):1235-1240. PubMed ID: 32588748
[TBL] [Abstract][Full Text] [Related]
4. The Impact of an Electronic Prescribing Template with Decision Support upon the Prescribing of Subcutaneous Infusions at the End of Life in a Community Setting: A Future Vision for Community Palliative Care.
Au YK; Baker L; Hindmarsh J
Pharmacy (Basel); 2022 Sep; 10(5):. PubMed ID: 36136845
[TBL] [Abstract][Full Text] [Related]
5. The financial costs of anticipatory prescribing: A retrospective observational study of prescribed, administered and wasted medications using community clinical records.
Morgan L; Barclay S; Pollock K; Massou E; Bowers B
Palliat Med; 2023 Dec; 37(10):1554-1561. PubMed ID: 37817429
[TBL] [Abstract][Full Text] [Related]
6. Anticipatory prescribing in community end-of-life care.
Lee C; Tran TT; Ross J
BMJ Support Palliat Care; 2023 Oct; ():. PubMed ID: 37852662
[TBL] [Abstract][Full Text] [Related]
7. How is agitation and restlessness managed in the last 24 h of life in patients whose care is supported by the Liverpool care pathway for the dying patient?
Gambles M; McGlinchey T; Latten R; Dickman A; Lowe D; Ellershaw JE
BMJ Support Palliat Care; 2011 Dec; 1(3):329-33. PubMed ID: 24653479
[TBL] [Abstract][Full Text] [Related]
8. Anticipatory prescribing in community end-of-life care: systematic review and narrative synthesis of the evidence since 2017.
Bowers B; Antunes BCP; Etkind S; Hopkins SA; Winterburn I; Kuhn I; Pollock K; Barclay S
BMJ Support Palliat Care; 2024 Jan; 13(e3):e612-e623. PubMed ID: 37236648
[TBL] [Abstract][Full Text] [Related]
9. A qualitative study of community nurses' decision-making around the anticipatory prescribing of end-of-life medications.
Bowers B; Redsell SA
J Adv Nurs; 2017 Oct; 73(10):2385-2394. PubMed ID: 28423478
[TBL] [Abstract][Full Text] [Related]
10. End-of-life care in illicit drug users: mapping medication use.
Ulrick P; Panozzo S; Marco D; Collins A; Philip J
BMJ Support Palliat Care; 2023 Dec; 13(e2):e266-e269. PubMed ID: 34001548
[TBL] [Abstract][Full Text] [Related]
11. Administering anticipatory medications in end-of-life care: a qualitative study of nursing practice in the community and in nursing homes.
Wilson E; Morbey H; Brown J; Payne S; Seale C; Seymour J
Palliat Med; 2015 Jan; 29(1):60-70. PubMed ID: 25070861
[TBL] [Abstract][Full Text] [Related]
12. Identification of drug combinations administered by continuous subcutaneous infusion that require analysis for compatibility and stability.
Dickman A; Bickerstaff M; Jackson R; Schneider J; Mason S; Ellershaw J
BMC Palliat Care; 2017 Mar; 16(1):22. PubMed ID: 28335763
[TBL] [Abstract][Full Text] [Related]
13. Anticipatory prescribing at the end of life in Lothian care homes.
Finucane AM; Stevenson B; Gardner H; McArthur D; Murray SA
Br J Community Nurs; 2014 Nov; 19(11):544-7. PubMed ID: 25381850
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of continuous subcutaneous infusions across seven NHS acute hospitals: is there potential for 48-hour infusions?
Baker J; Dickman A; Mason S; Bickerstaff M; Jackson R; McArdle A; Lawrence I; Stephenson F; Paton N; Kirk J; Waters B; Ellershaw J
BMC Palliat Care; 2020 Jul; 19(1):99. PubMed ID: 32635902
[TBL] [Abstract][Full Text] [Related]
15. Anticipatory prescribing in community end-of-life care in the UK and Ireland during the COVID-19 pandemic: online survey.
Antunes B; Bowers B; Winterburn I; Kelly MP; Brodrick R; Pollock K; Majumder M; Spathis A; Lawrie I; George R; Ryan R; Barclay S
BMJ Support Palliat Care; 2020 Sep; 10(3):343-349. PubMed ID: 32546559
[TBL] [Abstract][Full Text] [Related]
16. Pediatric Palliative Care at Home: A Prospective Study on Subcutaneous Drug Administration.
García-López I; Chocarro-González L; Martín-Romero I; Vázquez-Sánchez JM; Avilés-Martínez M; Martino-Alba R
J Pain Symptom Manage; 2023 Sep; 66(3):e319-e326. PubMed ID: 37244525
[TBL] [Abstract][Full Text] [Related]
17. Community prescribing for cancer patients at the end of life: a national study.
Emanuel G; Verne J; Forbes K; Hounsome L; Henson KE
BMJ Support Palliat Care; 2023 Dec; 13(e2):e361-e372. PubMed ID: 34083319
[TBL] [Abstract][Full Text] [Related]
18. Specialist Pediatric Palliative Care Prescribing Practices: A Large 5-year Retrospective Audit.
Damani A; Salins N; Ghoshal A; Muckaden M
Indian J Palliat Care; 2016; 22(3):274-81. PubMed ID: 27559255
[TBL] [Abstract][Full Text] [Related]
19. GPs' decisions about prescribing end-of-life anticipatory medications: a qualitative study.
Bowers B; Barclay SS; Pollock K; Barclay S
Br J Gen Pract; 2020 Oct; 70(699):e731-e739. PubMed ID: 32895243
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
